Literature DB >> 29059696

Social Morbidity in Relation to Bowel Functional Outcomes and Quality of Life in Anorectal Malformations and Hirschsprung's Disease.

Kristiina Kyrklund1, Malla I Neuvonen1, Mikko P Pakarinen1, Risto J Rintala1.   

Abstract

BACKGROUND: Anorectal malformations (ARMs) and Hirschsprung's disease (HD) are chronic bowel conditions associated with varying degrees of fecal incontinence. We aimed to discuss the contemporary status of social morbidity associated with ARMs and HD in the long term after contemporary treatments.
MATERIALS AND METHODS: The bowel functional outcomes of our recent institutional series up to adulthood were reviewed and compared for ARMs and HD. The Rintala score was used to evaluate bowel function, which includes an assessment of the social effects of the condition. In this study, the social outcomes in our population of patients with ARMs and HD were specifically analyzed in relation to the surveyed functional outcomes, our previously collected data on quality of life (QoL) and the current literature.
RESULTS: Mild ARMs were associated with a minimal risk of social morbidity consistent with good outcomes. In severe ARMs and HD, social problems were reported steadily among all age groups studied. Impairment of domains of fecal control were present among 53 to 89% of patients with social problems, including frequent symptoms (>1/week) in up to 39%. Involuntary gas leakage contributed to social morbidity in 15 to 27%. Comparison with QoL data suggested that social morbidity experienced during childhood may continue to affect emotional domains of QoL in later life, despite improvements in bowel function by adulthood.
CONCLUSION: Patients with severe ARMs and HD are at risk of social restrictions from impairment of bowel function despite contemporary surgical treatments. However, the QoL outcomes in adulthood may be more influenced by self-perceptions of illness formed from childhood than disease-specific factors. Strategies to reduce the psychological morbidity associated with these conditions that includes parental involvement from the outset may improve outcomes. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 29059696     DOI: 10.1055/s-0037-1607356

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  8 in total

1.  Resection margin histology may predict intermediate-term outcomes in children with rectosigmoid Hirschsprung disease.

Authors:  Lauren A Brooks; Kathryn L Fowler; Laura V Veras; Ming Fu; Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2020-06-06       Impact factor: 1.827

2.  Clinical outcomes and risk factors for postoperative complications in children with Hirschsprung's disease.

Authors:  Tingting Gao; Weijue Xu; Qingfeng Sheng; Ting Xu; Wei Wu; Zhibao Lv
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

3.  Identifying Needs, Challenges, and Benefits Among Adults and Parents of Children With Hirschsprung Disease.

Authors:  Courtney Berrios; Juli Bollinger; Jia Yan; Barbara Biesecker; Aravinda Chakravarti
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-05-01       Impact factor: 3.288

Review 4.  ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease.

Authors:  Kristiina Kyrklund; Cornelius E J Sloots; Ivo de Blaauw; Kristin Bjørnland; Udo Rolle; Duccio Cavalieri; Paola Francalanci; Fabio Fusaro; Annette Lemli; Nicole Schwarzer; Francesco Fascetti-Leon; Nikhil Thapar; Lars Søndergaard Johansen; Dominique Berrebi; Jean-Pierre Hugot; Célia Crétolle; Alice S Brooks; Robert M Hofstra; Tomas Wester; Mikko P Pakarinen
Journal:  Orphanet J Rare Dis       Date:  2020-06-25       Impact factor: 4.123

5.  Quality of Life and Anorectal Malformations: A Single-Center Experience.

Authors:  Gabriella Scirè; Riccardo Gabaldo; Ilaria Dando; Francesco S Camoglio; Nicola Zampieri
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-07-06

6.  Pan-enteric neuropathy and dysmotility are present in a mouse model of short-segment Hirschsprung disease and may contribute to post-pullthrough morbidity.

Authors:  Sukhada Bhave; Emily Arciero; Corey Baker; Wing Lam Ho; Richard A Guyer; Ryo Hotta; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2020-04-17       Impact factor: 2.545

7.  Optimal timing for Soave primary pull-through in short-segment Hirschsprung disease: A meta-analysis.

Authors:  Maggie L Westfal; Ongoly Okiemy; Patrick Ho Yu Chung; Jiexiong Feng; Changgui Lu; Go Miyano; Paul Kwong Hang Tam; Weibing Tang; Kenneth Kak Yuen Wong; Atsuyuki Yamataka; Richard A Guyer; Daniel P Doody; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2021-07-21       Impact factor: 2.545

8.  Total colonic aganglionosis: multicentre study of surgical treatment and patient-reported outcomes up to adulthood.

Authors:  P Stenström; K Kyrklund; M Bräutigam; H Engstrand Lilja; K Juul Stensrud; A Löf Granström; N Qvist; L Söndergaard Johansson; E Arnbjörnsson; H Borg; T Wester; K Björnland; M P Pakarinen
Journal:  BJS Open       Date:  2020-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.